DIMENSIONAL FUND ADVISORS LP - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,739
-83.7%
14,890
-74.4%
0.00%
Q2 2023$133,076
+633595.2%
58,112
+128.3%
0.00%
Q4 2022$21
-99.9%
25,459
-31.3%
0.00%
Q3 2022$30,000
-87.0%
37,051
-84.1%
0.00%
Q2 2022$231,000
-66.4%
232,817
-44.5%
0.00%
Q1 2022$687,000
-40.0%
419,140
-11.8%
0.00%
Q4 2021$1,145,000
+31.0%
475,081
+163.9%
0.00%
Q3 2021$874,000
-17.3%
180,034
-54.5%
0.00%
Q2 2021$1,057,000
-17.6%
395,829
-5.0%
0.00%
Q1 2021$1,283,000
-17.4%
416,649
-4.5%
0.00%
-100.0%
Q4 2020$1,553,000
-11.2%
436,2080.0%0.00%0.0%
Q3 2020$1,749,000
+46.6%
436,208
-0.5%
0.00%0.0%
Q2 2020$1,193,000
+29.0%
438,3830.0%0.00%
Q1 2020$925,000
-62.6%
438,383
-3.6%
0.00%
-100.0%
Q4 2019$2,472,000
+73.0%
454,671
-4.2%
0.00%0.0%
Q3 2019$1,429,000
-18.4%
474,634
+1.3%
0.00%0.0%
Q2 2019$1,752,000
+3.5%
468,534
+11.2%
0.00%0.0%
Q1 2019$1,693,000
+37.2%
421,280
+25.3%
0.00%0.0%
Q4 2018$1,234,000
-44.8%
336,327
+29.0%
0.00%0.0%
Q3 2018$2,237,000
+30.2%
260,701
+66.6%
0.00%0.0%
Q2 2018$1,718,000
+10.8%
156,471
+16.4%
0.00%0.0%
Q1 2018$1,550,000
+137.0%
134,436
+112.9%
0.00%
Q4 2017$654,000
+86.3%
63,136
+187.1%
0.00%
Q3 2017$351,000
+9.7%
21,993
-16.8%
0.00%
Q2 2017$320,00026,4430.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders